Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Theme
New Insights and Practical approaches of Diabetes
- Diabetes Meet 2020

About Conference

ABOUT CONFERENCE

It is an incredible delight and immense pleasure to invite participants from All over the world to attend international conference on Advanced Technologies in Diabetes Research on November 2-3, 2020 which incorporates incite keynote introductions, oral talks, and Poster Presentations.

Meet the Global Inspiring experts and speakers at our International Conference on Diabetic research and therapy 2020 which will focus in bringing together individuals who have an interest in different fields of Endocrinology, Diabetes and Metabolic Disorders like Endocrinologists, Diabetologists, Medical Professors, Researchers, Diabetes and Endocrinology Scientists, Practitioners, Physical trainer, Medical students.

Diabetes Meet 2020 highlights the theme “New Insights and Practical approaches of Diabetes” Which emphasis on the latest advancements in prevention and treatment cure of diabetic and endocrine complications and strategies related to diagnosis, prevention and management of metabolic disorders as well as explore new ideas and concepts for treatment of Endocrine Complications.

Why to attend diabetes and endocrinology 2020 Conference?

Medical doctors and health care providers consider the prevention of Endocrinology and metabolic disorders as an important tool to enhance the overall health status of the population. Diabetic and metabolic issue and also as exploring new thoughts and concepts for treatment of Endocrine Complications. It is a great opportunity to meet world’s Diabetes, Obesity & Heart Experts.

Benefits of attending

• One on One Meeting with Eminent Speakers

• Thought to provoke Symposiums and Workshops

Nominations for Best Poster Award

• Keynote sessions by world’s most eminent researchers

 

Target Audience

• Diabetologist

• Endocrinologists

• Endocrinology, Diabetes & Metabolism students, Scientists

• Endocrinology, Diabetes & Metabolism Faculty

• Endocrinology, Diabetes & Metabolism Researchers

Endocrinology, Diabetes & Metabolism Associations and Societies

• Gynaecologists

• Neurologists

Ophthalmologists

• Oncologists

• Primary care providers

• Community physicians

• Nutritionists/Dieticians

• Diabetes Health Professionals

• Physician assistants

• Registered nurses

• Diabetes educators, dieticians

• Pharmacists who provide interdisciplinary care

Welcome Message

WELCOME MESSAGE:

We are honored to welcome you to attend the “3rd Global experts meet on Advanced Technologies in Diabetes Research and Therapy” is a Webinar conference which is going to be held on November 2-3, 2020. Theme of the conference is “New Insights and Practical approaches of Diabetes”.

Diabetes mellitus is a group of metabolic disorders characterized by high blood sugar levels over a prolonged period. Diabetes is either because of the pancreas not creating adequate insulin, or the cells of the body are not reacting appropriately to the insulin delivered. Type 1 Diabetes: Pancreas fails to produce enough insulin due to loss of beta cells. It is also referred as insulin-dependent diabetes mellitus or juvenile diabetes. Type 2 Diabetes: a condition in which cells fail to respond to insulin properly. It was previously mentioned as “non-insulin dependent diabetes mellitus” or “adult onset diabetes”. The main cause is excess weight and insufficient exercise.

Session/Tracks

SESSIONS/TRACKS

Track 1: Diabetes

Diabetes may be a chronic disease that happens when the pancreas is not any longer ready to make insulin, or when the body cannot observe use of the insulin it produces.

Insulin may be a hormone made by the pancreas that acts sort of a key to let glucose from the food we eat pass from the blood stream into the cells in the body to produce energy. All carbohydrate foods are weakened into glucose within the blood. Insulin helps glucose get into the cells.

Not having the ability to supply insulin or use it effectively results in raised glucose levels within the blood (known as hyperglycaemia). Over the long-term high glucose levels are related to damage to the body and failure of varied organs and tissues.

 

·         Hypoglycaemia

·         Prediabetes

·         Type 1 Diabetes

·         Type 2 Diabetes

·         Gestational Diabetes (Diabetes During Pregnancy)

·         Diabetes Case Reports


Track 2: Genetics of Diabetes

Diabetes doesn't seem to be inherited during a simple pattern. However, a few people are brought into the world bound to create diabetes than others. Type 1 and sort 2 diabetes have different causes. Yet two factors are important in both. You acquire an inclination to the ailment; at that point something in your condition triggers it. Qualities alone are insufficient. One proof of this is indistinguishable twins. Indistinguishable twins have indistinguishable qualities. Yet when one twin has type 1 diabetes, the opposite gets the disease at the most only half the time. When one twin has type 2 diabetes, the other's risk is at the most 3 in 4.

Diabetes comprises a noteworthy general medical issue. Albeit generous advancement has been made in characterizing the hereditary hazard for explicit sub types of diabetes .The weight of diabetes may be a lot higher for racial/ethnic minorities than for whites. Minorities have a higher predominance of diabetes than whites, and a few minorities have higher paces of diabetes-related entanglements and passing.

Track 3: Diabetes Research and therapy

Diabetes research takes many forms throughout the world. Diabetes research is a global task. In this review, we explore what a perfect diabetes therapy would appear as if from the attitude of several key in diabetes drug development. Increased diabetes was the leading cause of blindness, kidney failure, and non-traumatic lower-limb amputations.

Diabetes therapies are described by their brand names to differentiate new therapies with generic names almost like those of existing therapies and to draw distinctions between separate therapies that share the same generic names.

  •          Anatomy of Endocrine system
  •          Endocrine Tissues and Organs
  •          Role of DNA methylation in insulin secretion
  •         Intravenous blood glucose monitoring systems
  •          Insulin dose calculation software
  •          Flash Glucose Monitoring.
  •          Closed-loop system and algorithm

 

Track 4: Diabetes medication


Anti-Diabetic Medications work by two mechanisms either lowering blood glucose level or by increasing sensitivity to insulin. People can self-inject insulin under the skin if hospitalized a doctor/nurse might inject insulin directly into the blood. 

There are several different types of insulin-like Rapid-acting injections that take less time to show effect i.e. within 5 to 15 minutes but lasts for a shorter time period of 3 to 5 hours, Short-acting injections take 30 minutes and 1 hour time to show effect and last for 6 to 8 hours. Intermediate-acting injections that take about 1 to 4 hours to show effect and it last for 10 to 26 hours, Long-acting injections show effect after 1 or 2 hours and it last for between 14 and 24 hours.

Other than insulin there are many other oral anti diabetic medications which are non-insulin injectable in the market. They include Biguanides, Sulphonylureas, Meglitinides, Thiazolidinedione, Alpha-Glycosidase Inhibitors, Gestational diabetes.

  • Neonatal diabetes
  • Paediatric diabetes
  • Factors considered in selecting proper medications
  • Bio availability and bio equivalence of drugs in diabetic patients

Track 5: Emerging Technologies for Diabetes Care

Diabetes is a serious issue which is still uncured and makes new research, in treatment and management techniques is a crucial necessity. Over the past years, there have been considerable breakthroughs in preventing diabetic complications by understanding them.

Nanotechnology in diabetes is the advancement of novel glucose estimation and insulin conveyance modalities that hold the possibility to drastically enhance the personal satisfaction for diabetics. Nano-medication is typically 10-100 times littler than a body's phone yet just minimal bigger than particles makes conceivable the treatment of the starting point of diabetes at the atomic level.

  • Nanotechnology  in diabetes
  • Artificial organ transplantation technology
  • Human Recombinant Insulin
  • Digital Healthcare: Designing the Digital Solution
  • Blood Glucose Monitoring and Glycemic Control in theHospitals
  • Computerised applications in Diabetes mitigations
  • Informatics in the Service of  Medicine, Telehealth, Telemedicine, Software and other Technologies
  • Clinical Decision Support Systems/Advisors
  • Securing funding for diabetes technology

Track 6: Medical Devices used in Diabetes Treatment

Most common medical devices used in diabetes diagnosis and treatment include blood-glucose meters, insulin pens, insulin pumps. These devices incorporate glucose serving gadgets, Bio-artificial pancreas, insulin delivery systems, and insulin administrating frameworks. And many diabetes monitoring and diagnostic devices like lancets, analog glucose monitor, test Strips, Syringe, Injectors also come under this. And these devices are designed to be feasible to use and painless in the insertion. Some companies are joining up and put their efforts to create a contact lens that measures the glucose in tears.

 

  • Insulin Pens and novel Insulin delivery techniques
  • Tear glucose monitoring contact lenses
  • Continuous glucose monitoring (CGM)/ Blood Glucose Meters
  • The future: the Artificial Beta Cell
  • Artificial pancreas
  • New Insulin Analogues
  • Blood glucose monitoring: Glucose pumps & sensors
  • Intravenous blood glucose monitoring systems
  • Insulin dose calculation software
  • Flash Glucose Monitoring.
  • Closed-loop system and algorithm
  • New insulin delivery systems: Inhaled, transdermal patches, and implanted devices

Track 7: Diabetes Management

Diabetes Management mainly aims to attenuate the danger of long-term consequences related to diabetes. It not only involves keeping a check on blood glucose, blood pressure, and cholesterol levels but also focussing on modern approaches like exercise, diet and lifestyle management often coupled with on-going blood glucose level monitoring. Self-management of diabetes is also another crucial thing for proper adherence to dietary and lifestyle modifications.

Regular check-ups on cholesterol, blood pressure, HDL, LDL & triglyceride levels, and eye examination to prevent diabetic retinopathy, foot care specialist is to prevent diabetes occurrence. And the other complications caused due to other diseases such are obesity, cancer are to be treated or prevented.

  • Diabetic Diet Management- Food, micronutrients
  • Clinical care management of Diabetes - Medication
  • Management of Neonatal and Pediatric diabetes
  • Management of Gestational Diabetes / Menstruation and menopause (Diabetic women)
  • Management of Diabetes hypertension / blood pressureManagement of Diabetic Cardiovascular Diseases
  • Management of Diabetic Eye Diseases
  • Management of Diabetic Kidney Diseases
  • Management of Diabetic Foot Diseases
  • Management of Neuro Diabetes
  • Management of Diabetes obesity

 

 

Track 8: Biomarkers and Biosimilars in Diabetes

Biosimilars are biological medical products/molecules which are almost identical copies of an original product manufactured by different companies and an already FDA-approved biological product, referred to as a reference product. Human bio monitoring (HBM) may be a tool of health-related environmental monitoring.

Diabetes may be a major lifestyle disease, it's necessary to spot potential biomarkers related to diabetes for early detection and proper management of diabetes. Biomarkers are known as signature molecules or molecular markers or biological molecules found in blood, tissues and other body fluids. Biomarkers are used to monitor how well the body is responding to a particular disease. Haemoglobin A1C is considered as a biomarker for the presence of Diabetes Mellitus biosimilars in diabetes.

 

  • Scope and Role of Biomarkers
  • Biomarker Application in diabetes research
  • Novel Biomarkers
  • Biosimilar Development, Review, and Approval
  • Biosimilar and Interchangeable Products
  • Prescribing Biosimilar and Interchangeable Products
  • Biosimilar Product Information

Track 9: Diabetic Nephropathy

Diabetic nephropathy also referred to as diabetic renal disorder is that the chronic loss of kidney function occurring in those with DM. Protein loss within the urine thanks to damage to the glomeruli may become tremendous, and causes a coffee albumin with resulting generalized body swelling and end in the nephrosis. For a few people, diabetic nephropathy can reach chronic renal disorder and renal failure. However, most of the people with diabetes don't develop renal disorder that progresses to renal failure.

The main is to filter waste products and excess water from the bloodstream in order that they will be excreted within the sort of urine. This is often administered by a system of tubes and blood vessels referred to as nephrons. Inside the nephrons are tiny blood vessels called capillaries and tiny urine-collecting tubes. One among the main structures within the nephron may be a group of blood vessels referred to as the glomerulus, which acts as a filter. Having high blood sugar levels can interfere with the function of the glomerulus. The filtering function of the kidneys doesn’t work properly and proteins start to leak from the blood into the urine.

 

·         Causes and Symptoms for diabetic nephropathy

·         Risk factors for diabetic nephropathy

·         What are the complications for diabetic nephropathy

·         Tests and diagnosis for diabetic nephropathy

·         Treatment for diabetic nephropathy

·         Prevention of diabetic nephropathy

 

Track 10: Diabetic Retinopathy

Diabetic retinopathy, also referred to as diabetic disease, may be a medical condition during which damage occurs to the retina thanks to DM. It is a leading cause of blindness. Diabetic retinopathy affects up to 80% of these who have had diabetes for 20 years or more. At least 90% of latest cases might be reduced with proper treatment and monitoring of the eyes. The retina is the membrane that covers the back of the eye. It is highly sensitive to light. It converts any light that hits the eye into signals that can be interpreted by the brain. This process produces visual images, and it's how sight functions within the human eye. Diabetic retinopathy damages the blood vessels within the retinal tissue, causing them to leak fluid and warp vision.

Diabetic retinopathy is that the results of damage to the tiny blood vessels and neurons of the retina. The earliest changes prompting diabetic retinopathy incorporate narrowing of the retinal veins related with diminished retinal blood stream; brokenness of the neurons of the internal retina, followed in later stages by changes within the function of the outer retina, related to subtle changes in visual function; dysfunction of the blood-retinal barrier, which protects the retina from many substances in the blood resulting in the leaking of blood constituents into the retinal neuropile.

 

·         What are the types of diabetic retinopathy?

·         What are the symptoms of diabetic retinopathy?

·         What causes diabetic retinopathy?

·         How is diabetic diabetic retinopathy?

·         How isdiabetic retinopathy treated?

·         How is diabetic retinopathy prevented?

 

Track 11:  Risk Factors and Related Diseases of Diabetes

Diabetes is usually amid variety of great health issues. Consistent increase in blood sugar levels can cause serious diseases affecting the vital organs of body like heart and blood vessels, eyes, kidneys, nerves and teeth. In most high-income countries, diabetes may be a leading explanation for disorder like diabetic cardiomyopathy being one among the main risk factor, blindness, renal failure, and lower limb amputation. Diabetic Retinopathy causes progressive damage to the retina within the patients with diabetes adding because the most vulnerable risk for the patient. Maintaining blood sugar levels, vital sign, diabetic gastro paresis which has been reported to possess the most cause as DM and cholesterol at or on the brink of normal can help delay or prevent diabetes complications.

 

  •          Blood glucose levels
  •         Cardiovascular disease
  •          Diabetic cardiomyopathy
  •         Kidney failure
  •          Diabetic Retinopathy
  • \         Diabetes Mellitus 
  •          Cholesterol

 

Track 12: Diabetic psychological care

The importance of the mental state consultants within the management of medically ill individuals has grown with the proliferation of data linking health and behaviour.

People with diabetes experience dis proportionately high rates of mental health issues such as anxiety, depression and eating disorders. Most of the studies state that folks with diabetes must have access to psychological treatment and support so as to scale back psychological distress and improve self-management.

 

 

Track 13: Pharmacogenetics Diabetes

Genomic studies have greatly advanced our understanding of the multifactorial aetiology of diabetes especially in type 2diabetes (Diabetes Mellitus) as well as the multiple subtypes of monogenic diabetes mellitus. These studies specialise in a couple of feasible candidate genes involved in drug pharmacodynamics / pharmacokinetics, or those related to Type 2 diabetes as a disease phenotype. Here in reference to diabetes the most focus is on mostly used drugs in diabetes treatment like sulfonylureas, metformin and thiazolidinedione (troglitazone, pioglitazone, and rosiglitazone).

 

         Genomics

         Chemo genomics

         Clinomics

         Genetic engineering

         Toxico genomics

         Metabolomics

         Pharmacovigilance

         Population groups in biomedicine

         Toxgnostics

         Medical terminology

 

Track 14: Diabetes: Health Education & Health Promotion

 Health education may be a combination of learning experiences designed to assist individuals or communities improve their health, by increasing their knowledge or influencing their attitudes, by that specialize in prevention. Diabetes education will reduce the prices that individuals, families, insurance companies, medical facilities, communities, the state, and therefore the nation would spend on medical treatment.

Health promotion is that the process of enabling people to extend control over and to enhance their health, it moves beyond attention on individual behaviour towards the wide selection of environmental and social interventions.

• Public Awareness Campaigns

• Promotional Initiatives – Webinars, Books & Publications

 

Track 15: Diabetes and its Complications

Excess amounts of sugars or glucose within the blood cause such a chronic condition called DM. High glucose in blood may cause eye damage, kidney damage, and nerve damage. Diabetes increases the risk of different cardiovascular diseases, such as coronary heart disease, heart attack, heart stroke and narrowing of arteries which diminishes the blood move through the arteries.

The abnormal rise of glucose in the blood can harm veins and nerves of the eye, which leads to loss of visions. Diabetes is the main cause of cardiovascular diseases, kidney diseases and loss of vision.

 

         Diabetic cardiomyopathy

         Diabetes insipidus

         Diabetic Nephropathy

         Diabetic Neuropathy

         Diabetic Retinopathy

         Diabetes Dermatology

         Diabetes Paediatrics

         Diabetes and Oral health

         Diabetes and Colo-Rectal Cancer

Market Analysis

MARKET ANALYSIS:

We are overwhelmed to announce “3rd global experts meet on Advanced technologies in Diabetes Research and Therapy'' is a Webinar which is going to be held during November 2-3, 2020.

DIABETES GLOBALLY: Diabetes is taken into account because the world’s fastest growing chronic condition. The type 2 diabetes is growing highly in each country. In 2013, diabetes caused 1.6 million deaths globally.

The World Diabetes Day is celebrated on November 14 each year. This day engages many diabetic patients worldwide in diabetes advocacy and awareness activities.

 Diabetes 2020 Conference invites all renowned scientists, dieticians, endocrinologists, primary health care specialists, surgeons, pharmaceutical industrial delegates, radiation therapists, general physicians, talented young scientists, and student communities across the world to attend International Diabetes congress.

 

Growing incidences of endocrine disorders such as hyperthyroidism and adrenal insufficiency is predicted to boost the demand for endocrine testing. Furthermore, growing healthcare awareness among individuals coupled with increasing government support is expected to increase the diagnosis at an early, thereby contributing to the growth of the endocrine testing market.

The players are actively involved in launching technologically advanced products and initiate collaborative developments to sustain themselves in the competition. For instance, LabCorp offers all-embracing solutions on clinical trials concerning diabetes and every one other hormonal disease.

The global Next Generation Diabetes Therapy and Drug Delivery Market generated $1.25 billion in 2017 and are estimated to succeed in $9.67 billion by 2023, growing at a CAGR of 40.6% from 2018 to 2023. The report offers an in depth analysis of adjusting market trends, key investment pockets, major segments, countries, and competitive scenario.

The CGM systems segment accounted for quite nine-tenths of the entire revenue in 2017 and can maintain its dominance by 2023. This is due to various benefits including ease of usability and detection of levels of blood glucose. The report also explores inhalable insulin, oral insulin, and artificial pancreas.

 

 

Importance & Scope:

Diabetes Meeting 2020 will feature the latest developments in research, diagnosis and prevention of diabetes, new insulin analogues, new technologies and devices for diabetes.

The Editors will concentrate on studies that involve wisely selected reports that provide a link between basic research and translation to diabetes-related diseases. The editors support the diffusion of distinctive solutions to challenging scientific and translational questions related with studies of Diabetes and metabolically/genetically related disorders.

Apparently, researcher’s out and out controls identified with Diabetes and different researchers dedicated to Glucose Metabolic Homeostasis and related subjects will engage as authors of JDRT articles. Most likely those studies would be focused on indicators of disease risk and mechanisms of glucose metabolic deregulations related diseases.

 List of Diabetes Universities in Worldwide:

• Monash University Malaysia

• International Medical University

• Asia Pacific University of Technology and Innovation

• Albert Einstein-Mount Sinai Diabetes Center

• Columbia University

• Indiana Diabetes Research Center

• Joslin Diabetes Center-Harvard Medical School

• Stanford Diabetes Research Center

• The University of Chicago Diabetes Research

• Washington University at St.Louis

• Kaiser foundation Research Institute ,California San Franciso

• University of Cambridge

• Johns Hopkins University

• Yale University

• University of California, Los Angeles (UCLA)

• Imperial College London

• University of Melbourne

• Karolinska Institute

 

List of Diabetes Associations Worldwide:

• Diabetes Australia

• Diabetes Australia Victoria

• Diabetes Canada

• Diabetes UK

• Diabetes.co.uk

• Diabetic Association of Bangladesh

• European Association for the Study of Diabetes

• Pacific Northwest Diabetes Research Institute

• German Diabetes Center Mergentheim

• Gulf Diabetes Specialist Center

• Kanungo Institute of Diabetes Specialities

• American Association of Clinical Endocrinologists

• American Diabetes Association

 

List of Diabetes Societies in Worldwide:

• German Diabetes Association

• FAND - Italian Association of Diabetics

• Italian Association for the Defence of the Interests of Diabetics

• Association of Diabetes

• Association National Italian Diabetic Athletes

• Italian Society of Diabetology

• International Diabetes Federation- Italy

• Primary Care Diabetes Society

• Australian Diabetes Society

• Emirates Diabetes Society

• Society for Biomedical Diabetes Research

• Immunology of Diabetes Society

• American Association of Diabetes Educators

• American Diabetes Association

• The Asian Association for the Study of Diabetes

• International Association of the Diabetes and Pregnancy Study Groups

• Diabetes Association of Nigeria

• Association of Children's Diabetes Clinicians

• Canadian Diabetes Association

 

Diabetic drugs:

 The 50+ diabetes drugs available within the world within the sort of tablets or injection suspension and placed into different drug’s classes.

• Insulin

• Biguanides / Metformin

• Sulphonylureas

• Meglitinides / Prandial glucose regulator / Glinides

• Alpha-glucosidase inhibitors

• Thiazolidinedione / Glitazones

• DPP-4 inhibitors / Gliptins

• Incretin mimetics / GLP-1 analogues

• Amylin analogues

Previous Organizing Committee
OCM Member
Gerald C. Hsu
Diabetes
EclaireMD Foundation
Indiana, USA
OCM Member
Magnus S Magnusson
Professor
University of Iceland
Iceland, Iceland
OCM Member
Dr. Ian Martins
Fellow of International Agency for Standards and Ratings (IASR)
Centre of Excellence for Alzheimer's Disease Research and Care Sarich Neuroscience Research Institute
Melbourne, Australia
OCM Member
Jaleel Kareem Ahmed
University of Babylon
Baghdad, Iraq
OCM Member
Mikhail Kolonin
The University of Texas
Dallas, USA

To Collaborate Scientific Professionals around the World

Conference Date November 2-3, 2020
Speaker Oppurtunity Day 1 Day 2
Poster Oppurtunity Available
e-Poster Oppurtunity Available
Join The Discussion

Allied Academies Global Conference Directory

Mail us at

General Enquires
meetdiabetes@gmail.com
Project Coordinator
meetdiabetes@gmail.com
WhatsApp Queries
meetdiabetes@gmail.com
More details about sponsorship:sponsors@alliedacademies.com

Terms and Conditions

Responsibility:

 

The organizers holds no responsibilities or liabilities of the personal articles of attendees at the venue against any kind of theft, lost, damage, due to any reason whatsoever. Delegates are entirely responsible for the safety of their own belongings.

Insurance:

 

No insurance, of any kind, is included along with the registration in any of the events of the organization.

 

Transportation:

 

Please note that transportation and parking is the responsibility of the registrant, Allied Academies will not be liable for any actions howsoever related to transportation and parking.

 

Press/Media:

 

Press permission must be obtained from Allied Academies Conference Organizing Committee prior to the event. The press will not quote speakers or delegates unless they have obtained their approval in writing. The Allied Academies is an objective third-party non-profit organization and this conference is not associated with any commercial meeting company.

 

Requesting an Invitation Letter:

 

For security purposes, letter of invitation will be sent only to those individuals who had registered for the conference after payment of complete registration fee. Once registration is complete, please contact diabetes@alliedevents.org to request for a personalized letter of invitation, if not received until one month before the scheduled date of event.

All the bank charges applicable during refund will be deducted from the account of participant.

 

Cancellation Policy:

 

All cancellations or modifications of registration must be made in writing to finance@alliedacademies.com If, due to any reason, Allied academies postpone an event on the scheduled date, the participant is eligible for a credit of 100% of the registration fee paid. This credit shall only be used for another event organized by Allied academies within period of one year from the date of rescheduling.

 

Postponement of event:

If, due to any reason, Allied academies postpone an event and the participant is unable or unwilling to attend the conference on rescheduled dates, he/she is eligible for a credit of 100% of the registration fee paid. This credit shall only be used for another event organized by Allied academies within period of one year from the date of rescheduling.

 

Transfer of Registration:

All registrations, after payment of complete registration fee, are transferable to other persons from the same organization, if in case the person is unable to attend the event. Request for transfer of registration must be made by the registered person in writing to support@alliedmeetings.com Details must include the full name of replaced new registrant, their title, contact phone number and email address. All other registration details will be assigned to the new person unless otherwise specified.

Registration can be transferred to one conference to another conference of Allied academies if the person is unable to attend one of conferences.

However, Registration cannot be transferred if intimated within 14 days of respective conference.

The transferred registrations will not be eligible for Refund.

This cancellation policy was last updated on April 04, 2015.

 

Visa Information:

Keeping in view of increased security measures, we would like to request all the participants to apply for Visa as soon as possible.

Allied academies will not directly contact embassies and consulates on behalf of visa applicants. All delegates or invitees should apply for Business Visa only.

Important note for failed visa applications: Visa issues are not covered under the cancellation policy of Allied academies, including the inability to obtain a visa.

 

Refund Policy:

If the registrant is unable to attend, and is not in a position to transfer his/her participation to another person or event, then the following refund policies apply:

Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overhead charges, following Refund Policy Orders are available:

Before 60 days of the conference: Eligible for Full Refund after deduction of $100 towards service Fee.

Within 60-30 days of Conference: Eligible for 50% of payment Refund

Within 30 days of Conference: Not eligible for Refund

E-Poster Payments will not be refunded.

 

Accommodation Cancellation Policy:

Accommodation Service Providers (Hotels) have their own cancellation policies which are applicable when cancellations are made less than 30 days prior to arrival. If in case the registrant wishes to cancel or amend the accommodation, he/ she is expected to inform the organizing authorities on a prior basis. Allied academies will advise the registrant to ensure complete awareness about the cancellation policy of your accommodation provider, prior to cancellation or modification of their booking.

 

Authorization Policy

Copyright © 2020-2021 Allied Academies, All Rights Reserved.